These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22430965)

  • 21. Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Gunderson BW; Ibrahim KH; Peloquin CA; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2003 Jan; 47(1):398-9. PubMed ID: 12499223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
    LaPlante KL; Mermel LA
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3166-9. PubMed ID: 19451302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
    Rybak MJ; Hershberger E; Moldovan T; Grucz RG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1062-6. PubMed ID: 10722513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonization of the tip of a thoracic catheter by Enterococcus faecalis resistant to vancomycin and linezolid.
    Cian F; Luzzati R; Deiana ML; Ferrantelli N; Tonin E; Lagatolla C; Dolzani L
    J Med Microbiol; 2009 Aug; 58(Pt 8):1118-1121. PubMed ID: 19528174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
    Sweeney MT; Zurenko GE
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1902-6. PubMed ID: 12760865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Hall AD; Steed ME; Arias CA; Murray BE; Rybak MJ
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3174-80. PubMed ID: 22470111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Curr Microbiol; 2011 Sep; 63(3):313-7. PubMed ID: 21761219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
    Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
    Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):655-9. PubMed ID: 23642281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection.
    Bayston R; Nuradeen B; Ashraf W; Freeman BJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1298-301. PubMed ID: 17959732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
    Livermore DM; Warner M; Mushtaq S; North S; Woodford N
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
    Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
    Schwameis R; Fille M; Manafi M; Zeitlinger M; Sauermann R
    Res Microbiol; 2012 Apr; 163(3):157-60. PubMed ID: 22210435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
    Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
    Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.